1 Follower


Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Beam is headquartered in Cambridge, Massachusetts.

Brian Riley
Senior Vice President of Technical Operations
Christine Bellon
Senior Vice President and Chief Legal Officer
Christine Swenson
SVP of Regulatory Affairs
Courtney Wallace
Senior Vice President, Head of Business Development and Strategy
Francine Gregoire
Vice President for Liver Diseases
Giuseppe Ciaramella
President and Chief Scientific Officer
Manmohan Singh
SVP of Pharmaceutical Sciences and Delivery Technologies
Susan O’connor
Chief Human Resources Officer
Suzanne Fleming
Senior Vice President, Finance
Terry-Ann Burrell
Chief Financial Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.